Rezolute (RZLT) Common Equity (2010 - 2026)
Rezolute (RZLT) reported Common Equity of $100.69 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 37.9% from $162.13 million a year earlier and down 13.8% from the prior quarter.
Powered by 
Analysis
Rezolute (RZLT) Common Equity (2010 - 2026) Analysis & Trends
Dating back to fiscal Q2 2011, Rezolute's Common Equity record includes 59 quarters.
- Common Equity has a five-year compound annual growth rate of 31.0% (FY2021 to FY2026).
- By fiscal year, Common Equity came in at $162.13 million in FY2025 (+34.0%), $121 million in FY2024 (+4.2%), $116.17 million in FY2023 (-22.3%) and $149.47 million in FY2022 (+472.7%).
- The fiscal Q4 2026 figure ranks as the lowest quarterly Common Equity since fiscal Q3 2025.
- Year over year, Common Equity gained in seven of the last eight quarters, with growth averaging 16.3%.
- The high point for year-over-year Common Equity in five years was fiscal Q1 2023 (growth of 610.1%); the low point was fiscal Q3 2024 (a decline of 44.3%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $116.83 million (Q3 2026), $128 million (Q2 2026) and $147.17 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Rezolute | 388.82 Mn | -62.24 Mn | - | 85.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 85.95 Mn |
| Jun 30, 2026 | 100.69 Mn |
| Mar 31, 2026 | 116.83 Mn |
| Dec 31, 2025 | 128.00 Mn |
| Sep 30, 2025 | 147.17 Mn |
| Jun 30, 2025 | 162.13 Mn |
| Mar 31, 2025 | 82.57 Mn |
| Dec 31, 2024 | 99.59 Mn |
| Sep 30, 2024 | 113.44 Mn |
| Jun 30, 2024 | 121.00 Mn |
| Mar 31, 2024 | 70.86 Mn |
| Dec 31, 2023 | 91.73 Mn |
| Sep 30, 2023 | 103.56 Mn |
| Jun 30, 2023 | 116.17 Mn |
| Mar 31, 2023 | 127.32 Mn |
| Dec 31, 2022 | 141.27 Mn |
| Sep 30, 2022 | 153.09 Mn |
| Jun 30, 2022 | 149.47 Mn |
| Mar 31, 2022 | 51.91 Mn |
| Dec 31, 2021 | 62.27 Mn |
API Access
Rezolute Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=RZLT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "RZLT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=RZLT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();